Should treatment of ALK‐positive anaplastic large cell lymphoma be stratified according to minimal residual disease?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Should treatment of ALK‐positive anaplastic large cell lymphoma be stratified according to minimal residual disease?

Published:2021-03-09 Issue:6 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Rigaud Charlotte¹^ORCID,Abbas Rachid²^ORCID,Grand David³,Minard‐Colin Véronique¹^ORCID,Aladjidi Nathalie⁴^ORCID,Buchbinder Nimrod⁵,Garnier Nathalie⁶,Plat Geneviève⁷,Couec Marie‐Laure⁸,Duplan Mylène⁹,Lambilliotte Anne¹⁰,Schmitt Claudine¹¹,Leblanc Thierry¹²,Lamant Laurence³,Brugières Laurence¹^ORCID

Affiliation:

1. Children and Adolescent Oncology Department Gustave Roussy Cancer Campus, Paris‐Saclay University Villejuif France

2. Department of Biostatistics and Epidemiology Gustave Roussy Cancer Campus, Paris‐Saclay University Villejuif France

3. Department of Pathology Institut Universitaire du Cancer Toulouse Oncopole Toulouse France

4. Pediatric Oncology Bordeaux University Hospital Bordeaux France

5. Pediatric Oncology Rouen University Hospital Rouen France

6. Pediatric Hematology and Oncology IHOP Lyon France

7. Pediatric Oncology Toulouse University Hospital Toulouse France

8. Pediatric Oncology Nantes University Hospital Nantes France

9. Pediatric Oncology Angers University Hospital Angers France

10. Pediatric Hematology Lille University Hospital Lille France

11. Pediatric Oncology Nancy University Hospital Nancy France

12. Pediatric Hematology Robert Debré Hospital‐APHP Paris France

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28982

Reference9 articles.

1. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining

2. Distribution ofNPM1-ALKandX-ALKfusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation

3. Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study

4. Prognostic Impact of Morphologic and Phenotypic Features of Childhood ALK-Positive Anaplastic Large-Cell Lymphoma: Results of the ALCL99 Study

5. Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK–positive anaplastic large-cell lymphoma

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimal residual disease detection in lymphoma: methods, procedures and clinical significance;Frontiers in Immunology;2024-08-12

2. Minimal Disseminated Disease Continues to Impact Outcomes Even in the Era of Targeted Therapy in Childhood ALK+ Anaplastic Large Cell Lymphoma, What More Do We Have to Offer?;South Asian Journal of Cancer;2024-07-10

3. Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application;Molecular Cancer;2024-02-17

4. Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents;Best Practice & Research Clinical Haematology;2023-03

5. Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials?;Cancers;2022-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3